WallStreetZenWallStreetZen

NYSE: CBT
Cabot Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cabot earnings were $380.0M for the trailing 12 months ending Sep 30, 2024, with -12.8% growth year over year. The latest CBT earnings report on Sep 30, 2024 announced Q3 2024 earnings of $137.0M, up 25.7% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, CBT reported annual earnings of $380.0M, with -14.6% growth. The next CBT earnings date is Feb 3, 2025.

CBT past earnings growth

How has CBT's earnings growth performed historically?

Company
-12.84%
Industry
16.87%
Market
48.77%
CBT's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CBT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CBT's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CBT earnings history

Current Revenue
$4.0B
Current Earnings
$380.0M
Current Profit Margin
9.5%
CBT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

CBT Return on Equity

Current Company
27.8%
Current Industry
21%
Current Market
35%
CBT's Return on Equity (27.8%)... subscribe to Premium to read more.
High Return on Equity Performance

CBT Return on Assets

Current Company
10.4%
Current Industry
6.7%
CBT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CBT announces earnings.

CBT Return on Capital Employed

Current Company
19.3%
Current Industry
12%
CBT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CBT vs Specialty Chemical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CBT$723.00M$380.00M+20.80%$6.79
NEU$712.55M$432.08M+13.59%$45.04
BCPC$225.37M$121.54M+8.83%$3.77
AVNT$467.60M$149.80M-1.29%$1.64
OLN$902.90M$150.80M+12.23%$1.30
View Top Specialty Chemical Stocks

CBT earnings dates

Next earnings date
Feb 3, 2025

Cabot Earnings Reports & History FAQ

What were Cabot's earnings last quarter?

On CBT's earnings call on Invalid Date, Cabot (NYSE: CBT) reported Q3 2024 earnings per share (EPS) of $2.45, up 40.39% year over year. Total CBT earnings for the quarter were $137.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $4.11.

If you're new to stock investing, here's how to buy Cabot stock.

When does Cabot report earnings?

The next CBT earnings date is Invalid Date. Add CBT to your watchlist to be reminded of Cabot's next earnings date.

What was CBT's earnings growth in the past year?

As of Cabot's earnings date in Invalid Date, Cabot's earnings has grown -12.84% year over year. This is 29.7 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 16.87%. CBT earnings in the past year totalled $380.00 million.

Is Cabot profitable or losing money?

As of the last Cabot earnings report, Cabot is currently profitable. Cabot's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $380.00 million, a 14.61% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.